tradingkey.logo

Stereotaxis Inc

STXS
2.445USD
+0.105+4.49%
收盤 12/22, 16:00美東報價延遲15分鐘
222.70M總市值
虧損本益比TTM

Stereotaxis Inc

2.445
+0.105+4.49%

關於 Stereotaxis Inc 公司

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Stereotaxis Inc簡介

公司代碼STXS
公司名稱Stereotaxis Inc
上市日期Aug 12, 2004
CEOFischel (David Leo)
員工數量139
證券類型Ordinary Share
年結日Aug 12
公司地址710 N Tucker Blvd
城市ST. LOUIS
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編63101
電話13146786100
網址https://www.stereotaxis.com/
公司代碼STXS
上市日期Aug 12, 2004
CEOFischel (David Leo)

Stereotaxis Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.92M
+0.31%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.97K
+9.43%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
345.11K
+14.49%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+42.86%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
138.64K
+45.98%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
89.28K
+95.75%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
13.92M
+0.31%
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
506.97K
+9.43%
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
345.11K
+14.49%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
200.00K
+42.86%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
138.64K
+45.98%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
89.28K
+95.75%

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
International
13.49M
50.12%
United States
13.43M
49.88%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 12月5日 週五
更新時間: 12月5日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Fischel (Nathan)
14.91%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
BlackRock Institutional Trust Company, N.A.
3.94%
其他
51.94%
持股股東
持股股東
佔比
Fischel (Nathan)
14.91%
Dafna Capital Management, LLC
14.66%
Kiani (Joe E)
9.49%
Lagoda Investment Management, L.P.
5.04%
BlackRock Institutional Trust Company, N.A.
3.94%
其他
51.94%
股東類型
持股股東
佔比
Individual Investor
28.55%
Hedge Fund
19.47%
Investment Advisor
16.89%
Investment Advisor/Hedge Fund
9.40%
Corporation
3.30%
Research Firm
0.62%
Bank and Trust
0.07%
Venture Capital
0.04%
Insurance Company
0.02%
其他
21.63%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
175
41.68M
45.77%
-4.01M
2025Q2
184
70.71M
77.86%
+13.38M
2025Q1
192
70.55M
82.04%
+9.72M
2024Q4
185
55.40M
64.94%
-4.27M
2024Q3
178
54.77M
64.71%
-4.91M
2024Q2
173
55.07M
66.24%
-4.36M
2024Q1
185
55.40M
67.15%
-4.49M
2023Q4
184
51.49M
64.77%
-9.27M
2023Q3
189
52.12M
65.60%
-9.17M
2023Q2
205
51.88M
65.54%
-5.57M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Fischel (Nathan)
13.92M
15.28%
+43.67K
+0.31%
Jul 01, 2025
Dafna Capital Management, LLC
13.68M
15.02%
--
--
Jun 30, 2025
Kiani (Joe E)
8.86M
9.73%
+427.40K
+5.07%
Mar 17, 2025
Lagoda Investment Management, L.P.
4.69M
5.15%
+307.45K
+7.02%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.60M
3.96%
+68.06K
+1.92%
Jun 30, 2025
The Vanguard Group, Inc.
3.30M
3.63%
-231.68K
-6.56%
Jun 30, 2025
2012 Revocable Trust of Andrew Redleaf
3.08M
3.38%
--
--
Mar 17, 2025
Arbiter Partners Capital Management, LLC
2.85M
3.13%
--
--
Jun 30, 2025
Isaac (Paul J)
2.05M
2.26%
+2.05M
--
Mar 10, 2025
Essex Investment Management Company, LLC
1.54M
1.7%
-11.34K
-0.73%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.03%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
佔比0.03%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0%
iShares Russell 2000 ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Stereotaxis Inc的前五大股東是誰?

Stereotaxis Inc的前五大股東如下:
Fischel (Nathan)
持有股份:13.92M
佔總股份比例:15.28%。
Dafna Capital Management, LLC
持有股份:13.68M
佔總股份比例:15.02%。
Kiani (Joe E)
持有股份:8.86M
佔總股份比例:9.73%。
Lagoda Investment Management, L.P.
持有股份:4.69M
佔總股份比例:5.15%。
BlackRock Institutional Trust Company, N.A.
持有股份:3.60M
佔總股份比例:3.96%。

Stereotaxis Inc的前三大股東類型是什麼?

Stereotaxis Inc 的前三大股東類型分別是:
Fischel (Nathan)
Dafna Capital Management, LLC
Kiani (Joe E)

有多少機構持有Stereotaxis Inc(STXS)的股份?

截至2025Q3,共有175家機構持有Stereotaxis Inc的股份,合計持有的股份價值約為41.68M,占公司總股份的45.77% 。與2025Q2相比,機構持股有所增加,增幅為-32.09%。

哪個業務部門對Stereotaxis Inc的收入貢獻最大?

在FY2024,--業務部門對Stereotaxis Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI